Capital expenditure · 2011–2025
Adma Biologics capital expenditure
$22.6M+174.4% · FY2025
Adma Biologics (ADMA) reported $22.6M in capital expenditure for fiscal 2025, +174.4% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $22.6M | +174.4% | Open → |
| FY20242024-12-31 | $8.2M | +72.4% | Open → |
| FY20232023-12-31 | $4.8M | −65.7% | Open → |
| FY20222022-12-31 | $13.9M | +3.0% | Open → |
| FY20212021-12-31 | $13.5M | +6.2% | Open → |
| FY20202020-12-31 | $12.7M | +233.9% | Open → |
| FY20192019-12-31 | $3.8M | +81.9% | Open → |
| FY20182018-12-31 | $2.1M | −21.7% | Open → |
| FY20172017-12-31 | $2.7M | +3,545.7% | Open → |
| FY20162016-12-31 | $73,410 | +181.6% | Open → |
| FY20152015-12-31 | $26,073 | −98.9% | Open → |
| FY20142014-12-31 | $2.3M | +1,081.5% | Open → |
| FY20132013-12-31 | $196,635 | +65.4% | Open → |
| FY20122012-12-31 | $118,853 | +43,919.6% | Open → |
| FY20112011-12-31 | $270 | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +124.7%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Adma Biologics capital expenditure |url=https://companiesranked.com/en/company/adma-biologics/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Adma Biologics capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/adma-biologics/capital-expenditureBibTeX
@misc{companiesranked-en-company-adma-biologics-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Adma Biologics capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/adma-biologics/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001140361-26-006815 · February 25, 2026
{{cite web |title=Adma Biologics capital expenditure — 10-K (0001140361-26-006815) |url=https://www.sec.gov/Archives/edgar/data/1368514/000114036126006815/ef20059416_10-k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-25}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.